Announcements

Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)

Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Issuance and Allotment of 6,500,000 New Ordinary Shares in the Capital of the Company

Issuance and Allotment of 7,500,000 New Ordinary Shares in the Capital of the Company

Respond to SGX Queries on Proposed US$50M Share Swap

Singapore eDevelopment Limited Performance Share Plan (1) Receipt of Listing and Quotation Notice; and (2) Updates to Grants of Shares Awards Under the Singapore eDevelopment Limited Performance Share Plan

Entry Into Share Exchange Agreement in Relation To Proposed US$50 Million Share Swap

Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer

Impact Biomedical’s Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts